| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $282,492,292 ) (Continued on the next page) |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI148452 | Vanderbilt Vaccine and Treatment Evaluation Unit | 000 | 7 | NIH | 1/23/2026 | $561,977 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI148452 | Vanderbilt Vaccine and Treatment Evaluation Unit | 000 | 7 | NIH | 1/23/2026 | $51,280 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 3841 Green Hills Village Drive | Nashville | TN | 37215-2691 | DAVIDSON | USA | 90DDUC0153 | Vanderbilt Kennedy Center for Excellence in Developmental Disabilities | 00 | 2 | ACL | 7/1/2026 | $629,042 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK131070 | The Origins of Human Anti-Insulin B Lymphocytes in Type 1 Diabetes | 000 | 5 | NIH | 1/15/2026 | $421,441 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DC019648 | A taxonomic articulation-focused approach to dysarthria classification | 000 | 5 | NIH | 5/18/2026 | $567,594 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R13DC021381 | Early Career Development of Clinician-scientists in Otolaryngology and the Communication Sciences | 001 | 4 | NIH | 7/10/2026 | $32,029 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01MH135028 | Ultra-high resolution imaging of category-selective visual cortex in autism | 001 | 3 | NIH | 7/17/2026 | $683,350 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 001 | 3 | NIH | 1/12/2026 | $93,723 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 3 | NIH | 12/25/2025 | $17,925 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 3 | NIH | 12/25/2025 | $56,277 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 3 | NIH | 12/25/2025 | $80,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HG012262 | Rational Integration of Polygenic Risk Scores (RIPS) | 000 | 5 | NIH | 4/2/2026 | $863,677 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI180038 | Human M Cells Require Coronin 1a | 000 | 3 | NIH | 12/31/2025 | $706,382 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HD113675 | Utility of human milk oligosaccharides against the perinatal pathogen, Group B Streptococcus | 000 | 3 | NIH | 7/23/2026 | $353,540 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL171731 | Effect of infant antibiotics on the development of the early-life airway and gut microbiome and risk of childhood asthma | 000 | 3 | NIH | 7/15/2026 | $859,471 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R35GM155339 | From genetic variants to mechanisms: understanding drivers of inflammation | 000 | 3 | NIH | 4/24/2026 | $437,500 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NUR3DD000107 | Tennessee ADDM: Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 02 | 4 | CDC | 7/31/2026 | $245,190 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NUR3DD000107 | Tennessee ADDM: Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 02 | 4 | CDC | 7/31/2026 | $401,220 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NUR3DD000107 | Tennessee ADDM: Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 01 | 4 | CDC | 5/18/2026 | $275,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NUR3DD000107 | Tennessee ADDM: Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 00 | 4 | CDC | 1/5/2026 | $450,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01DK140952 | Improving disease subtyping and physiological characterization of adult-onset diabetes in electronic health records | 001 | 3 | NIH | 8/20/2026 | $867,269 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI182159 | GLP-1R agonist immune targets in lean and obesity-associated asthma | 000 | 3 | NIH | 7/14/2026 | $745,797 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL170020 | Identification of Early HFpEF after Preeclampsia by Exercise Stress Testing | 000 | 3 | NIH | 7/29/2026 | $841,313 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK139048 | Beyond Urea Kinetics: Balancing Tradeoffs in Dialyzer Design for the Next 50 Years | 002 | 3 | NIH | 8/10/2026 | $482,146 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL181174 | Prospective Investigation of Cirrhotic Cardiomyopathy in Humans | 000 | 2 | NIH | 8/3/2026 | $755,072 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA279249 | Secondary Molecular Imaging (SMI) for head and neck cancer | 001 | 3 | NIH | 4/16/2026 | $38,167 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA279249 | Secondary Molecular Imaging (SMI) for head and neck cancer | 000 | 3 | NIH | 1/30/2026 | $343,509 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL173598 | Novel functions of plasminogen and its diverse cargo in blood | 000 | 3 | NIH | 4/28/2026 | $350,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL164820 | Non-selective Large Conductance Ion Channels In Triggered Arrhythmia | 000 | 3 | NIH | 5/28/2026 | $535,427 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01MH137024 | Testing the role of belief updating in persecutory delusions | 000 | 3 | NIH | 5/20/2026 | $816,761 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL174052 | Leveraging Large-Scale Biobanks to Discover and Define Rare Variant Effects in Hypertrophic Cardiomyopathy | 000 | 3 | NIH | 8/7/2026 | $654,551 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK133512 | Hepatic stellate cells in liver homeostasis and regeneration | 000 | 3 | NIH | 12/29/2025 | $616,459 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AR084312 | Immune cell contributions to inflammatory arthritis | 001 | 2 | NIH | 5/14/2026 | $35,976 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AR084312 | Immune cell contributions to inflammatory arthritis | 000 | 2 | NIH | 3/24/2026 | $647,571 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | DP1DA056667 | Framework to Accelerate Substance Use Disorder Genetic Studies through Customizable, EHR-Based Precision Phenotyping | 000 | 6 | NIH | 7/30/2026 | $525,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08DK132507 | Examining how the novel S64F MAFA variant produces glucose intolerance or hypoglycemia in a sex-dependent manner | 000 | 5 | NIH | 5/19/2026 | $158,436 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK133530 | MOVE Trial: MOtiVational Strategies to Empower African Americans to Improve Dialysis Adherence | 000 | 5 | NIH | 7/9/2026 | $547,195 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | OT2OD035404 | All of Us Research Program Data and Research Center | 003 | 1 | NIH | 7/24/2026 | $401,263 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | OT2OD035404 | All of Us Research Program Data and Research Center | 002 | 1 | NIH | 4/21/2026 | $1,500,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | OT2OD035404 | All of Us Research Program Data and Research Center | 001 | 1 | NIH | 12/19/2025 | $2,500,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | OT2OD035404 | All of Us Research Program Data and Research Center | 003 | 1 | NIH | 7/24/2026 | $100,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | OT2OD035404 | All of Us Research Program Data and Research Center | 003 | 1 | NIH | 7/24/2026 | $1,350,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01LM013995 | Strategies for Engineering Reliable Value Sets (SERVS) | 002 | 3 | NIH | 6/18/2026 | $393,750 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K24HL165163 | Mentoring in cholinergic regulation of vascular oxidation | 000 | 4 | NIH | 8/11/2026 | $115,983 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K0149070 | Geriatric Academic Career Awards | 00 | 4 | HRSA | 5/29/2026 | $94,488 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23AA031068 | Development and Testing of an Integrated Care Coordination Intervention for Alcohol Use Disorder Recovery after Liver Transplantation | 001 | 4 | NIH | 8/19/2026 | $176,904 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R03HL177130 | The association of placental gene expression and newborn metabolic profiles in understanding childhood asthma pathogenesis | 000 | 2 | NIH | 4/2/2026 | $131,965 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25HG012915 | FIGOR: Fellowship In Genomics Outcomes Research | 000 | 4 | NIH | 7/21/2026 | $269,484 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R35GM150465 | High-throughput discovery of disease-associated ion channel variants | 000 | 4 | NIH | 4/17/2026 | $437,500 |
|
